Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
295 participants
INTERVENTIONAL
2016-11-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomised, Controlled Trial of an Individual Deprescribing Intervention for Nursing Homes Residents
NCT03655405
How do Older Adults and Caregivers Feel About Their Medications?
NCT03233971
Deprescribing in a Long Term Care Facility
NCT03091153
Efficacy and Feasibility of De-prescribing Rounds in a Singapore Rehabilitative Hospital- a Pilot Randomized Controlled Trial
NCT03713112
Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M)
NCT05756478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
naive Deprescribing arm
Team-based deprescribing practice, Deprescribing Guide
Team-care deprescribing with deprescribing guide
Beers criteria 2015, STOPP criteria 2014, drug interaction
naive Wait-list Control arm
No interventions assigned to this group
non-naive Deprescribing arm
Team-based deprescribing practice, Deprescribing Guide
Team-care deprescribing with deprescribing guide
Beers criteria 2015, STOPP criteria 2014, drug interaction
non-naive Wait-list Control arm
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Team-care deprescribing with deprescribing guide
Beers criteria 2015, STOPP criteria 2014, drug interaction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The healthcare professional is practicing in the involved nursing homes.
1. Accepted informed consent (unless cognitive-impaired, with no or un-contactable next-of-kin),
2. Adult aged 65 years and above,
3. Currently on five or more medications.
Exclusion Criteria
For team-care deprescribing study:
1. Below the age of 65 years of age,
2. Life expectancy of less than 6 months or respite care.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Monash University
OTHER
National Healthcare Group, Singapore
OTHER_GOV
Tan Tock Seng Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kua Chong Han
PhD Intern
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chong Han Kua
Role: PRINCIPAL_INVESTIGATOR
Monash University/Tan Tock Seng Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nursing homes
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kua CH, Yeo CYY, Char CWT, Tan CWY, Tan PC, Mak VS, Lee SWH, Leong IY. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol. BMJ Open. 2017 May 9;7(5):e015293. doi: 10.1136/bmjopen-2016-015293.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/00422
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.